Actions of psychotropic drugs beyond their primary targets at the synaptic cleft
- 16 June 2006
- journal article
- editorial
- Published by Springer Nature in European Archives of Psychiatry and Clinical Neuroscience
- Vol. 256 (5) , 265-267
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- The role of the transporter P-glycoprotein for disposition and effects of centrally acting drugs and for the pathogenesis of CNS diseasesEuropean Archives of Psychiatry and Clinical Neuroscience, 2006
- High activity of acid sphingomyelinase in major depressionJournal of Neural Transmission, 2005
- Region specific distribution of levomepromazine in the human brainJournal of Neural Transmission, 2005
- Long-term sequestration of fluorinated compounds in tissues after fluvoxamine or fluoxetine treatment: a fluorine magnetic resonance spectroscopy study in vivoMagnetic Resonance Materials in Physics, Biology and Medicine, 2004
- Polymorphism in the P-glycoprotein drug transporter MDR1 genePharmacogenetics, 2003
- Indinavir concentrations and St John's wortThe Lancet, 2000
- Herb-drug interactionsThe Lancet, 2000
- Persistence of Haloperidol in Human Brain TissueAmerican Journal of Psychiatry, 1999
- 3H-spiperone binding sites in post-mortem brains from schizophrenic patients: Relationship to neuroleptic drug treatment, abnormal movements, and positive symptomsJournal of Neural Transmission, 1989
- Central D2-Dopamine Receptor Occupancy in Schizophrenic Patients Treated With Antipsychotic DrugsArchives of General Psychiatry, 1988